본문 바로가기
KERD
논문KCI 등재

NDRG2-mediated Modulation of SOCS3 and STAT3 Activity Inhibits IL-10 Production

김혜리|김애영|강경아|임종석|이은별
대한면역학회 (The Korean Association of Immunologists)|2010.12|Immune Network|제10권 제6호|pp. 219-229

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

IL-10STAT3NDRG2SOCS3U937

초록

Background: N-myc downstream regulated gene 2 (NDRG2) is a member of the NDRG gene family. Our previous report indicated a possible role for NDRG2 in regulating the cytokine, interleukin-10 (IL-10), which is an important immunosuppressive cytokine. Several pathways, including p38-MAPK, NF-κB, and JAK/STAT, are used for IL-10 production, and the JAK/STAT pathway can be inhibited in a negative feedback loop by the inducible protein, SOCS3. In the present study, we investigated the effect of NDRG2 gene expression on IL-10 signaling pathway that is modulated via SOCS3 and STAT3. Methods: We generated NDRG2-overexpressing U937 cell line (U937-NDRG2) and treated the cells with PMA to investigate the role of NDRG2 in IL-10 production. U937 cells were also transfected with SOCS3- or NDRG2-specific siRNAs to examine whether the knockdown of SOCS3 or NDRG2 influenced IL-10 expression. Lastly, STAT3 and SOCS3 induction was measured to identify the signaling pathway that was associated with IL-10 production. Results: RT-PCR and ELISA assays showed that IL-10 was increased in U937-mock cells upon stimulation with PMA, but IL-10 was inhibited by overexpression NDRG2. After PMA treatment, STAT3 phosphorylation was decreased in a time-dependent manner in U937- mock cells, whereas it was maintained in U937-NDRG2 cells. SOCS3 was markedly reduced in U937-NDRG2 cells compared with U937-mock cells. IL-10 production after PMA stimulation was reduced in U937 cells when SOCS3 was inhibited, but this effect was less severe when NDRG2 was inhibited. Conclusion: NDRG2 expression modulates SOCS3 and STAT3 activity, eventually leading to the inhibition of IL-10 production.

Abstract

Background: N-myc downstream regulated gene 2 (NDRG2) is a member of the NDRG gene family. Our previous report indicated a possible role for NDRG2 in regulating the cytokine, interleukin-10 (IL-10), which is an important immunosuppressive cytokine. Several pathways, including p38-MAPK, NF-κB, and JAK/STAT, are used for IL-10 production, and the JAK/STAT pathway can be inhibited in a negative feedback loop by the inducible protein, SOCS3. In the present study, we investigated the effect of NDRG2 gene expression on IL-10 signaling pathway that is modulated via SOCS3 and STAT3. Methods: We generated NDRG2-overexpressing U937 cell line (U937-NDRG2) and treated the cells with PMA to investigate the role of NDRG2 in IL-10 production. U937 cells were also transfected with SOCS3- or NDRG2-specific siRNAs to examine whether the knockdown of SOCS3 or NDRG2 influenced IL-10 expression. Lastly, STAT3 and SOCS3 induction was measured to identify the signaling pathway that was associated with IL-10 production. Results: RT-PCR and ELISA assays showed that IL-10 was increased in U937-mock cells upon stimulation with PMA, but IL-10 was inhibited by overexpression NDRG2. After PMA treatment, STAT3 phosphorylation was decreased in a time-dependent manner in U937- mock cells, whereas it was maintained in U937-NDRG2 cells. SOCS3 was markedly reduced in U937-NDRG2 cells compared with U937-mock cells. IL-10 production after PMA stimulation was reduced in U937 cells when SOCS3 was inhibited, but this effect was less severe when NDRG2 was inhibited. Conclusion: NDRG2 expression modulates SOCS3 and STAT3 activity, eventually leading to the inhibition of IL-10 production.

참고문헌 (43)

  1. Kim YJ, "NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells", Int J Cancer, 124, pp.7~15 (2009)
  2. Choi SC, "Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells", FEBS Lett, 553, pp.413~418 (2003)
  3. Park Y, "SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells", Biochem Biophys Res Commun, 363, pp.361~367 (2007)
  4. Liu N, "N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis", Nucleic Acids Res, 36, pp.5335~5349 (2008)
  5. O'Garra A, "Strategies for use of IL-10 or its antagonists in human disease", Immunol Rev, 223, pp.114~113 (2008)
  6. Choi YK, "Effective inhibition of glomerulosclerosis by adenoviral vector expressing human IL-10", Korean J Immunol, 22, pp.187~195 (2000)
  7. Staples KJ, "IL-10 induces IL-10 in primary human monocyte-derived macrophages via the transcription factor Stat3", J Immunol, 178, pp.4779~4785 (2007)
  8. Bettelli E, "IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice", J Immunol, 161, pp.3299~3306 (1998)
  9. Dai WJ, "Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice", J Immunol, 158, pp.2259~2267 (1997)
  10. Weber-Nordt RM, "Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain", J Biol Chem, 271, pp.27954~27961 (1996)
  11. Wehinger J, "IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes", FEBS Lett, 394, pp.365~370 (1996)
  12. Finbloom DS, "IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes", J Immunol, 155, pp.1079~1090 (1995)
  13. O'Garra A, "Regulatory T cells and mechanisms of immune system control", Nat Med, 10, pp.801~805 (2004)
  14. Akira S, "Toll-like receptor signalling", Nat Rev Immunol, 4, pp.499~511 (2004)
  15. Saraiva M, "The regulation of IL-10 production by immune cells", Nat Rev Immunol, 10, pp.170~181 (2010)
  16. Williams L, "Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages", J Immunol, 172, pp.567~576 (2004)
  17. Stumhofer JS, "Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10", Nat Immunol, 8, pp.1363~1371 (2007)
  18. Batten M, "Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells", J Immunol, 180, pp.2752~2756 (2008)
  19. Xu J, "c-Maf regulates IL-10 expression during Th17 polarization", J Immunol, 182, pp.6226~6236 (2009)
  20. Kalliolias GD, "IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38", J Immunol, 180, pp.6325~6333 (2008)
  21. Hebenstreit D, "Signaling mechanisms, interaction partners, and target genes of STAT6", Cytokine Growth Factor Rev, 17, pp.173~188 (2006)
  22. Qin H, "Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes", J Immunol, 181, pp.3167~3176 (2008)
  23. Alexander WS, "The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response", Annu Rev Immunol, 22, pp.503~529 (2004)
  24. Yoshimura A, "Negative regulation of cytokine signaling and immune responses by SOCS proteins", Arthritis Res Ther, 7, pp.100~110 (2005)
  25. Ding Y, "Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses", J Immunol, 170, pp.1383~1391 (2003)
  26. Yasukawa H, "IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages", Nat Immunol, 4, pp.551~556 (2003)
  27. Alexander WS, "Suppressors of cytokine signalling (SOCS) in the immune system", Nat Rev Immunol, 2, pp.410~416 (2002)
  28. Murray PJ, "STAT3-mediated anti-inflammatory signalling", Biochem Soc Trans, 34, pp.1028~1031 (2006)
  29. Zhou RH, "Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart", Genomics, 73, pp.86~97 (2001)
  30. Choi SC, "Expression of human NDRG2 by myeloid dendritic cells inhibits down-regulation of activated leukocyte cell adhesion molecule (ALCAM) and contributes to maintenance of T cell stimulatory activity", J Leukoc Biol, 83, pp.89~98 (2008)
  31. Bradshaw CD, "Effects of phorbol ester on phospholipase D and mitogen-activated protein kinase activities in T-lymphocyte cell lines", Immunol Lett, 53, pp.69~76 (1996)
  32. Schultz H, "PMA-induced activation of the p42", 44ERK- and p38RK-MAP kinase cascades in HL-60 cells is PKC dependent but not essential for differentiation to the macrophage-like phenotype, 1997, pp.173, 310~318
  33. Sengupta TK, "Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases", Proc Natl Acad Sci USA, 95, pp.11107~11112 (1998)
  34. Terstegen L, "The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130", J Biol Chem, 275, pp.18810~18817 (2000)
  35. Terstegen L, "Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA", FEBS Lett, 478, pp.100~104 (2000)
  36. Lagunas L, "Deregulated NFATc1 activity transforms murine fibroblasts via an autocrine growth factor-mediated Stat3-dependent pathway", J Cell Biochem, 108, pp.237~248 (2009)
  37. Wang T, "Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells", Nat Med, 10, pp.48~54 (2004)
  38. Borland G, "Activation of protein kinase Calpha by EPAC1 is required for the ERK- and CCAAT", enhancer-binding protein beta-dependent induction of the SOCS-3 gene by cyclic AMP in COS1 cells, 2009, pp.284, 17391~17403
  39. Boyle K, "The role of SOCS3 in modulating leukaemia inhibitory factor signalling during murine placental development", J Reprod Immunol, 77, pp.1~6 (2008)
  40. Fukushima A, "Pro-inflammatory cytokines induce suppressor of cytokine signaling-3 in human periodontal ligament cells", J Endod, 36, pp.1004~1008 (2010)
  41. Dong Q, "Over-expression of SOCS-3 gene promotes IL-10 production by JEG-3 trophoblast cells", Placenta, 30, pp.11~14 (2009)
  42. Berlato C, "Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation", J Immunol, 168, pp.6404~6411 (2002)
  43. Niemand C, "Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3", J Immunol, 170, pp.3263~3272 (2003)

이 간행물의 다른 논문 (8건)

Involvement of Hepatic Innate Immunity in Alcoholic Liver Disease정원일, 변진석pp. 181-187Dendritic Cell Activation by Glucan Isolated from Umbilicaria Esculenta김지윤, 이경애, 이홍경, 김무성, 홍진태, 한상배, 김환묵, 강종순, 김형숙, 김영수, 이상린pp. 188-197Codelivery of IL-7 Augments Multigenic HCV DNA Vaccine-induced Antibody as well as Broad T Cell Responses in Cynomolgus Monkeys송미영, 임세진, 남효정, 성영철, 박수형pp. 198-205Induction of 90K-specific Cytotoxic T Lymphocytes for Colon Cancer Immunotherapy이지희, 정익주, 박명숙pp. 206-211The Stem Bark of Kalopanax pictus Exhibits Anti-inflammatory Effect through Heme Oxygenase-1 Induction and NF-κB Suppression김지희, 박가영, 방수영, 김영희, 이상준, 이윤경, 박선영pp. 212-218
원문 보기